<?xml version="1.0" encoding="UTF-8"?>
<p>Further evaluation of dosage and need for booster injection of these vaccines is in process. An international agenda is needed so that the diverse issues will be systematically investigated. Several high-priority vaccines need to be evaluated at various frequencies of administration and dose levels, with and without adjuvants. No single country can do it adequately (
 <xref ref-type="bibr" rid="R10">
  <italic>10</italic>
 </xref>). The work has started, especially with the A (H5N1) vaccine produced by reverse genetics, but the research has a long way to go.
</p>
